# Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal

> **NCT05169619** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 842 (actual)

## Conditions studied

- Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05169619
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2024-03-06
- **Final completion:** 2024-03-06
- **Target enrollment:** 842 (ACTUAL)
- **Last updated:** 2025-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05169619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05169619, "Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05169619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*